pharmaphorum2y
Boehringer, Takeda make it into global top 15 employer list
Boehringer Ingelheim and Takeda are the only ... for help and be able to rely on each other's support when in need." Japan's Takeda – in the top 15 for the sixth consecutive year – said ...
emjreviews.com1d
FDA fast-tracks Boehringer’s NSCLC drug review
The FDA has granted Priority Review to Boehringer Ingelheim's new drug application for its non-small cell lung cancer therapy ...
pharmaphorum9d
Ono, Boehringer add to cancer pipelines with licensing deals
The Japanese drugmaker's clinical-stage pipeline ... keeping them inactive until they reach the tumour site. Meanwhile, Boehringer's agreement with South San Francisco-based Circle Pharma ...
Boehringer’s zongertinib receives Priority Review from U.S. FDA for the treatment of HER2 (ERBB2)-mutant advanced non-small cell lung cancer
Ridgefield, Conn., U.S., and Ingelheim, GermanyZongertinib would be the first orally administered, targeted therapy for previously treated ...
Contract Pharma1d
FDA Grants Priority Review to Boehringer Ingelheim’s NDA for Zongertinib
The U.S. Food and Drug Administration (FDA) has granted Priority Review to Boehringer Ingelheim’s new drug application for zongertinib (BI 1810631) for the treatment of adult patients with ...